Long-Term Care Edition

Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

New Product of the Week

DUTOPROL

5/21/2012

AstraZeneca Pharmaceuticals

Pharmacological Class: Cardioselective β₁-blocker + diuretic.

Active Ingredient(s): Metoprolol succinate extended-release, hydrochlorothiazide; 25/12.5mg, 50/12.5mg, 100/12.5mg; tablets.

Indication: Hypertension.

Isentress Receives New Labeling Update

May 21, 2012

Merck announced that the FDA has approved a labeling update for Isentress (raltegravir) tablets to include 156-week data from the STARTMRK study.

ASCO: Abiraterone Tolerated in High-Risk Prostate Cancer

May 17, 2012

For men with localized high-risk prostate cancer, neoadjuvant androgen deprivation therapy with abiraterone acetate (AA) plus leuprolide acetate (LHRHa) is well tolerated and has good pathological complete/near complete response (pCR/near pCR) rates.

Statins Benefit Those at Low Risk for Vascular Events

May 17, 2012

Reduction of low-density lipoprotein (LDL) cholesterol with statins is associated with a decrease in major vascular events, even for individuals with a five-year risk of <10%.

Catholic institutions challenge contraception mandate in court

McKnight's Staff May 22, 2012

More than 40 U.S. Catholic institutions have filed 12 lawsuits challenging the Affordable Care Act's requirement that employers cover contraceptive services in their health plans.

Nursing home quality scores are on the rise, federal data shows

McKnight's Staff May 22, 2012

The quality of care in U.S. nursing homes is improving, according to newly released federal health data. In evaluating the scores of 15,000 skilled nursing facilities across the country, the Centers for Medicare & Medicaid Services found that the proportion of 4- and 5-Star centers has increased 4% and 4.1%, respectively.